Zhao, Jean
- Dana-Farber Cancer Institute (no department on record)
- Crimson Biopharm Inc (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #6,244
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$1.4M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#6,244
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Zhao, Jean as a PI. Multi-PI records show the full award amount for context.
- 2R35CA210057-08R35Contact PIIntegrating targeted therapy and immunotherapy to break through cancer$1Maward amount
- 1R41CA281586-01R41Contact PITargeting glioblastoma with CM93, a novel EGFR inhibitor with exceptional brain penetration$400Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Zhao, Jean as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardDana-Farber Cancer Institute
- 2009$500K Cumulative Funding
- 2009Multi-Institutional ResearchAwards at 2 institutions
- 2010$1M Cumulative Funding
- 2013$2M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #5599
- 2017$5M Cumulative Funding
- 2023$10M Cumulative Funding